Editorial

Rectal Stents as an Alternative to Surgery

Authors: Jay P. Babich MD, David M. Friedel MD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Smith AS, Cole M, Vega KJ, et al. Palliation of malignant rectal obstruction from invasive prostate cancer with multiple overlapping self-expanding metal stents. South Med J 2009;102:1257–1259.SmithAS]]ColeM]]VegaKJ&etal;Palliation of malignant rectal obstruction from invasive prostate cancer with multiple overlapping self-expanding metal stents.South Med J20091021257-12592. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.JemalA]]SiegelR]]WardE&etal;Cancer statistics, 2008.CA Cancer J Clin20085871-963. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-instituitional update. JAMA 1997;277:1445–1451.PartinAW]]KattanMW]]SubongEN&etal;Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-instituitional update.JAMA19972771445-14514. Galper SL, Chen MH, Catalona WJ, et al. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol 2006;175:907–912.GalperSL]]ChenMH]]CatalonaWJ&etal;Evidence to support a continued stage migration and decrease in prostate cancer specific mortality.J Urol2006175907-9125. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007;177:2106–2131.ThompsonI]]ThrasherJB]]AusG&etal;Guideline for the management of clinically localized prostate cancer: 2007 update.J Urol20071772106-21316. Simmons DT, Baron TH. Technology insight: enteral stenting and new technology. Nat Clin Pract Gastroenterol Hepatol 2005;2:365–374.SimmonsDT]]BaronTHTechnology insight: enteral stenting and new technology.Nat Clin Pract Gastroenterol Hepatol20052365-3747. Baron TH, Kozarek RA. Endoscopic stenting of colonic tumours. Best Pract Res Clin Gastroenterol 2004;18:1:209–229.8. Friedland S, Hallenbeck J, Soetikno RM. Stenting in the sigmoid colon in a terminally ill patient with prostate cancer. J Palliat Med 2001;4:153–156.FriedlandS]]HallenbeckJ]]SoetiknoRMStenting in the sigmoid colon in a terminally ill patient with prostate cancer.J Palliat Med20014153-1569. Lujan M, Llorente C, Romero I, et al. Application of self-expanding stents in prostate cancer with rectal involvement. Report of two cases and review of the literature. Eur Urol 1997;31:251–253.LujanM]]LlorenteC]]RomeroI&etal;Application of self-expanding stents in prostate cancer with rectal involvement. Report of two cases and review of the literature.Eur Urol199731251-253